Segment reporting (Tables)

3 Months Ended

Nov. 30, 2023

Segment Reporting [Abstract]

Reconciliation of Operating Income (Loss) from Segments to Consolidated

The following table reflects results of operations of the Company’s reportable segments (in millions):

	Three months ended November 30,
	2023		2022
Sales:
U.S. Retail Pharmacy	$	28,944	$	27,204
International	5,832		5,189
U.S. Healthcare	1,931		989
Walgreens Boots Alliance, Inc.	$	36,707	$	33,382
Adjusted operating income:
U.S. Retail Pharmacy	$	694	$	1,105
International	142		116
U.S. Healthcare	(96)		(152)
Corporate and Other	(53)		(56)
Walgreens Boots Alliance, Inc.	$	687	$	1,014

The following table reconciles adjusted operating income to operating loss (in millions):

	Three months ended November 30,
	2023		2022
Adjusted operating income (Non-GAAP measure)	$	687	$	1,014
Acquisition-related amortization	(275)		(330)
Acquisition-related costs	(163)		(39)
Transformational cost management	(109)		(138)
Certain legal and regulatory accruals and settlements	(82)		(6,554)
Adjustments to equity earnings in Cencora	(50)		(86)
LIFO provision	(48)		(18)
Operating loss (GAAP measure)	$	(39)	$	(6,151)